Rachel McCormick

Rachel McCormick

Auto-generated profile, based on publicly available information

Rachel McCormick

Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, VIC, Australia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2020 in Sports Medicine
Verified
Journal Article
Closed access
PDF file
RMRachel McCormick
Rachel McCormick
MSMarc Sim
Marc Sim
BDBrian Dawson
Brian Dawson
PPPeter Peeling
Peter Peeling

13 April 2017 in European Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
PPPeter Peeling
Peter Peeling
AMAlannah K. A. McKay
Alannah K. A. McKay
DPDavid Pyne
David Pyne
KGKym J. Guelfi
Kym J. Guelfi
RMRachel H. McCormick
Rachel H. McCormick
LBLouise M. Burke
Louise M. Burke

2 May 2019 in Medicine & Science in Sports & Exercise
Verified
Journal Article
Closed access
RMRachel Mccormick
Rachel Mccormick
DMDiego Moretti
Diego Moretti
AMAlannah K. A. Mckay
Alannah K. A. Mckay
CLCoby M. Laarakkers
Coby M. Laarakkers
RVRachel Vanswelm
Rachel Vanswelm
PPPeter Peeling
Peter Peeling
Purpose: This study examined postexercise inflammatory, hepcidin, and iron absorption responses to endurance exercise performed in the morning versus the afternoon. Methods: Sixteen endurance-trained runners (10 male, 6 female) with serum ferritin (sFer) < 50 μg·L−1 completed a 90-min running protocol (65% vV˙O2max) in the morning (am), or the afternoon (pm), in a crossover design. An iron-fortified fluid labeled with stable iron isotopes (57Fe or 58Fe) was administered with a standardized meal 30 min following the exercise and control conditions during each trial, serving as a breakfast and dinner meal. Venous blood samples were collected before, immediately after, and 3 h after the exercise and control conditions to measure sFer, serum interleukin-6 (IL-6), and serum hepcidin-25. A final venous blood sample was collected 14 d after each trial to determine the erythrocyte iron incorporation, which was used to calculate iron absorption. Linear mixed-modeling was used to analyze the data. Results: Overall, exercise significantly increased the concentrations of IL-6 (4.938 pg·mL−1; P = 0.006), and hepcidin-25 concentrations significantly increased 3 h after exercise by 0.380 nM (P < 0.001). During the pm trial, hepcidin concentrations exhibited diurnal tendency, increasing 0.55 nM at rest (P = 0.007), before further increasing 0.68 nM (P < 0.001) from prerun to 3 h postrun. Fractional iron absorption was significantly greater at breakfast after the am run, compared with both the rested condition (0.778%; P = 0.020) and dinner in the am run trial (0.672%; P = 0.011). Conclusions: Although exercise resulted in increased concentrations of IL-6 and hepcidin, iron was best absorbed in the morning after exercise, indicating there may be a transient mechanism during the acute postexercise window to promote iron absorption opposing the homeostatic regulation by serum hepcidin elevations.

1 January 2024 in International Journal of Sport Nutrition and Exercise Metabolism
Verified
Journal Article
Closed access
PDF file
Megan KuikmanMegan Kuikman
Megan Kuikman
AMAlannah McKay
Alannah McKay
CMClare Minahan
Clare Minahan
RHRachel Harris
Rachel Harris
KEKirsty Elliott-Sale
Kirsty Elliott-Sale
LBLouise M. Burke
Louise M. Burke
The cyclical changes in sex hormones across the menstrual cycle (MC) are associated with various biological changes that may alter resting metabolic rate (RMR) and body composition estimates. Hormonal contraceptive (HC) use must also be considered given their impact on endogenous sex hormone concentrations and synchronous exogenous profiles. The purpose of this study was to determine if RMR and dual-energy X-ray absorptiometry body composition estimates change across the MC and differ compared with HC users. This was accomplished during a 5-week training camp involving naturally cycling athletes (n = 11) and HC users (n = 7 subdermal progestin implant, n = 4 combined monophasic oral contraceptive pill, n = 1 injection) from the National Rugby League Indigenous Women’s Academy. MC phase was retrospectively confirmed via serum estradiol and progesterone concentrations and a positive ovulation test. HC users had serum estradiol and progesterone concentrations assessed at the time point of testing. Results were analyzed using general linear mixed model. There was no effect of MC phase on absolute RMR (p = .875), relative RMR (p = .958), or dual-energy X-ray absorptiometry body composition estimates (p > .05). There was no effect of HC use on absolute RMR (p = .068), relative RMR (p = .309), or fat mass estimates (p = .766), but HC users had a greater fat-free mass and lean body mass than naturally cycling athletes (p = .028). Our findings suggest that RMR and dual-energy X-ray absorptiometry body composition estimates do not significantly differ due to changes in sex hormones in a group of athletes, and measurements can be compared between MC phases or with HC usage without variations in sex hormones causing additional noise.

1 May 2020 in International Journal of Sport Nutrition and Exercise Metabolism
Verified
Journal Article
Closed access
PDF file
RMRachel McCormick
Rachel McCormick
ADAlex Dreyer
Alex Dreyer
BDBrian Dawson
Brian Dawson
MSMarc Sim
Marc Sim
LLLeanne Lester
Leanne Lester
PPPeter Peeling
Peter Peeling
The authors compared the effectiveness of daily (DAY) versus alternate day (ALT) oral iron supplementation in athletes with suboptimal iron. Endurance-trained runners (nine males and 22 females), with serum ferritin (sFer) concentrations <50 μg/L, supplemented with oral iron either DAY or ALT for 8 weeks. Serum ferritin was measured at baseline and at fortnightly intervals. Hemoglobin mass (Hbmass) was measured pre- and postintervention in a participant subset (n = 10). Linear mixed-effects models were used to assess the effectiveness of the two strategies on sFer and Hbmass. There were no sFer treatment (p = .928) or interaction (p = .877) effects; however, sFer did increase (19.7 μg/L; p < .001) over the 8-week intervention in both groups. In addition, sFer was 21.2 μg/L higher (p < .001) in males than females. No Hbmass treatment (p = .146) or interaction (p = .249) effects existed; however, a significant effect for sex indicated that Hbmass was 140.85 g higher (p = .004) in males compared with females. Training load (p = .001) and dietary iron intake (p = .015) also affected Hbmass. Finally, there were six complaints of severe gastrointestinal side effects in DAY, but only one in ALT. In summary, both supplement strategies increased sFer in athletes with suboptimal iron status; however, the ALT approach was associated with lower incidence of gastrointestinal upset.

21 August 2025 in Sports Medicine
Verified
Journal Article
Open access
PDF file
JWJamie Whitfield
Jamie Whitfield
AMAlannah McKay
Alannah McKay
NTNicolin Tee
Nicolin Tee
RMRachel McCormick
Rachel McCormick
AMAimee Morabito
Aimee Morabito
JHJohn Alan Hawley
John Alan Hawley
Background: Urolithin A (UA) is a metabolite produced by gut bacteria following the consumption of ellagitannin-rich foods. Clinical trials in middle-aged and older adults demonstrated that supplementation with UA improves muscle strength, endurance, and biomarkers of mitochondrial health, suggesting that UA may be an effective ergogenic aid in other populations. Methods: In this double-blind, parallel group, placebo-controlled clinical trial (NCT04783207), competitive male distance runners ( n = 42, 27.2 ± 1.0 years, $$\dot{V}{\text{O}}_{{{\text{2max}}}}$$ V ˙ O 2max 66.4 ± 0.6 mL·kg −1 ·min −1 , mean ± SEM) were randomized to consume either 1000 mg·day −1 UA ( n = 22) or placebo (PL; n = 20) for 4 weeks during an altitude training camp (~ 1700–2200 m). Physiological outcomes including body composition, hemoglobin mass, running economy, and maximal aerobic capacity ( $$\dot{V}{\text{O}}_{{{\text{2max}}}}$$ V ˙ O 2max ) were measured in all subjects at baseline and at the end of the 4-week camp to assess training- and supplementation-induced adaptations. During the camp, a weekly downhill running bout was performed to challenge skeletal muscle, with capillary blood samples collected to assess inflammation (C-reactive protein; CRP) and indirect markers of muscle damage (creatine kinase; CK). A subset of athletes also either completed a 3000 m track time trial ( n = 11 PL, n = 11 UA) or had skeletal muscle biopsies taken ( n = 9 PL, n = 11 UA) pre/post supplementation to determine the effect of UA on running performance and for exploration of alterations in skeletal muscle proteome and mitochondrial function, respectively. Results: Running performance (3000 m time trial) was not significantly improved in either treatment group (UA; p = 0.116, PL; p = 0.771), although UA supplementation significantly lowered ratings of perceived exertion (RPE, p = 0.02) and reduced indirect markers of post-exercise muscle damage (CK, total area under the curve p < 0.0001) following the 3000 m time trial compared with PL. Although there was no statistically significant time × treatment interaction for aerobic capacity ( p = 0.138), UA supplementation showed a large within-group increase in $$\dot{V}{\text{O}}_{{{\text{2max}}}}$$ V ˙ O 2max (5.4 ± 0.9%, 66.4 ± 0.8 to 70.0 ± 1.0 mL·kg −1 ·min −1 , p = 0.009, d = − 0.83), with a smaller increase in the PL group (3.6 ± 1.3%, 66.4 ± 0.9 to 68.7 ± 1.0 mL·kg −1 ·min −1 , p = 0.098, d = − 0.54). Proteomic screening of skeletal muscle biopsies revealed UA upregulated pathways associated with mitochondria, while downregulating inflammatory pathways. While not statistically significant, UA led to a medium effect for increased markers of mitophagy ( d = − 0.74), without changes in mitochondrial function. Conclusions: Our results show that 4 weeks of daily UA supplementation facilitates recovery by downregulating inflammatory pathways and indirect markers of muscle damage. However, despite a reduction in rating of exertion and increased aerobic capacity, UA supplementation did not further enhance performance in highly trained male endurance athletes.